Cargando…
Multi-conformation representation of Mpro identifies promising candidates for drug repurposing against COVID-19
The COVID-19 main protease (Mpro), one of the conserved proteins of the novel coronavirus is crucial for its replication and so is a very lucrative drug target. Till now, there is no drug molecule that has been convincingly identified as the inhibitor of the function of this protein. The current pan...
Autores principales: | Paul, Debarati, Basu, Debadrita, Ghosh Dastidar, Shubhra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052536/ https://www.ncbi.nlm.nih.gov/pubmed/33864532 http://dx.doi.org/10.1007/s00894-021-04732-1 |
Ejemplares similares
-
Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing
por: Bernal, Leonardo, et al.
Publicado: (2023) -
Drug repurposing for COVID-19: Approaches, challenges and promising candidates
por: Ng, Yan Ling, et al.
Publicado: (2021) -
Ethacrynic Acid: A Promising Candidate for Drug Repurposing as an Anticancer Agent
por: Yu, Lu, et al.
Publicado: (2023) -
An understanding of coronavirus and exploring the molecular dynamics simulations to find promising candidates against the Mpro of nCoV to combat the COVID-19: A systematic review
por: Singh, Madhur Babu, et al.
Publicado: (2022) -
Repurposing Old Drugs into New Epigenetic Inhibitors: Promising Candidates for Cancer Treatment?
por: Moreira-Silva, Filipa, et al.
Publicado: (2020)